H. Lundbeck plans to acquire Longboard Pharmaceuticals in a $2.6 billion deal, the companies announced Monday.

智通财经APP获悉，丹麦制药巨头Lundbeck表示将以26亿美元的股权价值收购Longboard Pharmaceuticals ...

Longboard Pharmaceuticals Inc.的股价已达到令人印象深刻的里程碑，创下58.92美元的历史新高。这一峰值反映了投资者信心的显著增强，从公司673.36%的一年涨幅可见一斑。制药行业一直密切关注Longboard ...

丹麦瓦尔比和美国加利福尼亚州拉霍亚 - H. Lundbeck A/S (Lundbeck)和Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) (Longboard)已达成协议，Lundbeck将收购临床阶段生物制药公司Longboard。这笔交易的股权价值约为26亿美元，扣除现金后净值为25亿美元。此次收购将通过增加Longboard的主要资产bexi ...

两家公司周一表示，Lundbeck将以每股60美元的现金收购Longboard，较Longboard上周五38.90美元的收盘价溢价54%。此外，两家公司表示，该交易预计于今年年底完成，扣除Longboard现金后的价值约为25亿美元。

Pharmaceutical company Lundbeck will acquire Nasdaq-listed Longboard Pharmaceutical in a $2.6 billion deal, the two companies ...

Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc in a $2.6 billion deal that boosts its drug pipeline for serious ...

Denmark-based H. Lundbeck A/S on Monday agreed to acquire Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) for $60.00 per share ...

Danish pharmaceutical company Lundbeck will buy Longboard Pharmaceuticals (LBPH) in a deal valued at $2.6 billion, with the ...

After spying blockbuster potential in Longboard Pharmaceuticals’ epilepsy med, brain disease-focused pharma Lundbeck is ...

The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals in a deal worth $2.6 billion ...

H Lundbeck agreed to acquire Longboard Pharmaceuticals in a US$2.6 billion deal that boosts its drug pipeline for serious ...